{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T13:02:31Z","timestamp":1785934951321,"version":"3.56.0"},"reference-count":46,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2009,4,9]],"date-time":"2009-04-09T00:00:00Z","timestamp":1239235200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["bpspubs.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["British J Pharmacology"],"published-print":{"date-parts":[[2009,6]]},"abstract":"<jats:p><jats:bold>Background and purpose:\u2002<\/jats:bold>The atypical antipsychotic drug, zotepine, is effective in treatment of schizophrenia and acute mania, but the incidence of seizures during treatment is higher than with other antipsychotics. In addition, the mechanisms underlying the clinical actions of zotepine remain uncharacterized.<\/jats:p><jats:p><jats:bold>Experimental approach:\u2002<\/jats:bold>The effects of intraperitoneal administration of zotepine and haloperidol on the extracellular levels of noradrenaline, dopamine, 5\u2010HT, GABA, and glutamate in the medial prefrontal cortex (mPFC) were compared. Neuronal activities induced by each drug in the ventral tegmental area (VTA), locus coeruleus (LC), dorsal raphe nucleus (DRN) and mediodorsal thalamic nucleus (MTN) were also analysed.<\/jats:p><jats:p><jats:bold>Key results:\u2002<\/jats:bold>Haloperidol did not affect extracellular neurotransmitter levels in the mPFC. In contrast, zotepine activated neuronal activities in all nuclei and increased the extracellular levels of noradrenaline, dopamine, GABA, and glutamate in the mPFC, but not 5\u2010HT levels. The zotepine\u2010stimulated neuronal activity in the VTA, LC, DRN and MTN enhanced the release of dopamine, noradrenaline, 5\u2010HT, glutamate and GABA in the mPFC, although the enhanced GABAergic transmission possibly inhibited noradrenaline, dopamine and 5\u2010HT release. The other afferent to mPFC, which releases dopamine and noradrenaline, was partially insensitive to GABAergic inhibition, but possibly received stimulatory AMPA\/glutamatergic regulation from the MTN.<\/jats:p><jats:p><jats:bold>Conclusions and implications:\u2002<\/jats:bold>Our results indicated that the positive interaction between prefrontal catecholaminergic transmission and AMPA\/glutamatergic transmission from MTN might explain the regulatory effects of zotepine on neurotransmitter release. A mechanism is suggested to account for the pharmacological profile of this atypical antipsychotic and for its pro\u2010convulsive action.<\/jats:p><jats:p><jats:italic>British Journal of Pharmacology<\/jats:italic>(2009)<jats:bold>157,<\/jats:bold>656\u2013665; doi:10.1111\/j.1476\u20105381.2009.00175.x; published online 9 April 2009<\/jats:p>","DOI":"10.1111\/j.1476-5381.2009.00175.x","type":"journal-article","created":{"date-parts":[[2009,4,9]],"date-time":"2009-04-09T18:50:02Z","timestamp":1239303002000},"page":"656-665","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":51,"title":["Effects of zotepine on extracellular levels of monoamine, GABA and glutamate in rat prefrontal cortex"],"prefix":"10.1111","volume":"157","author":[{"given":"S","family":"Yamamura","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K","family":"Ohoyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T","family":"Hamaguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Nakagawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T","family":"Matsumoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E","family":"Motomura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H","family":"Tanii","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T","family":"Shiroyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Okada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2009,6,3]]},"reference":[{"key":"e_1_2_8_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-3223(01)01195-7"},{"key":"e_1_2_8_3_1","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/S0022-3565(25)28462-2","article-title":"Action of psychotogenic drugs on single midbrain raphe neurons","volume":"171","author":"Aghajanian GK","year":"1970","journal-title":"J Pharmacol Exp Ther"},{"key":"e_1_2_8_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/0006-8993(77)90083-X"},{"key":"e_1_2_8_5_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-5618.2005.00241.x"},{"key":"e_1_2_8_6_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1167.2007.01408.x"},{"key":"e_1_2_8_7_1","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/S0022-3565(25)29539-8","article-title":"Dopaminergic neurons: effect of antipsychotic drugs and amphetamine on single cell activity","volume":"185","author":"Bunney BS","year":"1973","journal-title":"J Pharmacol Exp Ther"},{"issue":"10","key":"e_1_2_8_8_1","first-page":"28","article-title":"In vitro and in vivo biochemistry of olanzapine: a novel, atypical antipsychotic drug","volume":"58","author":"Bymaster FP","year":"1997","journal-title":"J Clin Psychiatry"},{"key":"e_1_2_8_9_1","first-page":"55","article-title":"The relationship of pharmacology to side effects","volume":"58","author":"Casey DE","year":"1997","journal-title":"J Clin Psychiatry"},{"key":"e_1_2_8_10_1","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4684-7971-3_18"},{"key":"e_1_2_8_11_1","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD001948.pub2"},{"key":"e_1_2_8_12_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-4159.2004.02866.x"},{"key":"e_1_2_8_13_1","first-page":"78","article-title":"Clozapine dose in the United States and Europe: implications for therapeutic and adverse effects","volume":"55","author":"Fleischhacker WW","year":"1994","journal-title":"J Clin Psychiatry"},{"key":"e_1_2_8_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0893-133X(00)00087-7"},{"key":"e_1_2_8_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0028-3908(98)00188-9"},{"key":"e_1_2_8_16_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.mp.4001558"},{"key":"e_1_2_8_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.schres.2006.03.048"},{"key":"e_1_2_8_18_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1819.1992.tb00829.x"},{"key":"e_1_2_8_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0014-2999(98)00308-2"},{"key":"e_1_2_8_20_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1460-9568.1992.tb00154.x"},{"key":"e_1_2_8_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0301-0082(97)00070-1"},{"key":"e_1_2_8_22_1","doi-asserted-by":"publisher","DOI":"10.1093\/cercor\/10.10.974"},{"key":"e_1_2_8_23_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-006-0664-0"},{"key":"e_1_2_8_24_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.npp.1301356"},{"key":"e_1_2_8_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pnpbp.2003.09.010"},{"key":"e_1_2_8_26_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-2007-979481"},{"key":"e_1_2_8_27_1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.162.9.1733"},{"key":"e_1_2_8_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2005.10.045"},{"key":"e_1_2_8_29_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjp.0701941"},{"key":"e_1_2_8_30_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1460-9568.1999.00415.x"},{"key":"e_1_2_8_31_1","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.21-02-00628.2001"},{"key":"e_1_2_8_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2004.04.019"},{"key":"e_1_2_8_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuroscience.2005.03.045"},{"key":"e_1_2_8_34_1","unstructured":"PaxinosG WatsonC(1998).The rat brain in stereotoxic coordinates 4th Ed.Academic Press San Diego."},{"key":"e_1_2_8_35_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0024-3205(00)00911-5"},{"key":"e_1_2_8_36_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0028-3908(98)00094-X"},{"key":"e_1_2_8_37_1","doi-asserted-by":"publisher","DOI":"10.1007\/s002109900170"},{"key":"e_1_2_8_38_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0014-2999(99)00005-9"},{"key":"e_1_2_8_39_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1471-4159.2003.02238.x"},{"key":"e_1_2_8_40_1","doi-asserted-by":"publisher","DOI":"10.1016\/0306-4522(87)92964-2"},{"key":"e_1_2_8_41_1","doi-asserted-by":"publisher","DOI":"10.1016\/0304-3940(90)90841-V"},{"key":"e_1_2_8_42_1","doi-asserted-by":"publisher","DOI":"10.1002\/cne.902170406"},{"key":"e_1_2_8_43_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0014-2999(98)00711-0"},{"key":"e_1_2_8_44_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjp.0704608"},{"key":"e_1_2_8_45_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0014-2999(97)01435-0"},{"key":"e_1_2_8_46_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0893-133X(00)00119-6"},{"key":"e_1_2_8_47_1","doi-asserted-by":"publisher","DOI":"10.1254\/jphs.FP0040044"}],"container-title":["British Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1476-5381.2009.00175.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/bpspubs.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1476-5381.2009.00175.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,8]],"date-time":"2025-02-08T22:44:50Z","timestamp":1739054690000},"score":1,"resource":{"primary":{"URL":"https:\/\/bpspubs.onlinelibrary.wiley.com\/doi\/10.1111\/j.1476-5381.2009.00175.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,6]]},"references-count":46,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2009,6]]}},"alternative-id":["10.1111\/j.1476-5381.2009.00175.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1476-5381.2009.00175.x","archive":["Portico"],"relation":{},"ISSN":["0007-1188","1476-5381"],"issn-type":[{"value":"0007-1188","type":"print"},{"value":"1476-5381","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,6]]},"assertion":[{"value":"2009-06-03","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}